1,3,6,7-Tetramethyl-4,5-dicarboxyethyl-2,8-divinylbilenone. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of AMPHIBIANS and of birds, but not in normal human bile or serum.

Crystallization of recombinant human heme oxygenase-1. (1/201)

Heme oxygenase catalyzes the NADPH, O2, and cytochrome P450 reductase dependent oxidation of heme to biliverdin and carbon monoxide. One of two primary isozymes, HO-1, is anchored to the endoplasmic reticulum membrane via a stretch of hydrophobic residues at the C-terminus. While full-length human HO-1 consists of 288 residues, a truncated version with residues 1-265 has been expressed as a soluble active enzyme in Escherichia coli. The recombinant enzyme crystallized from ammonium sulfate solutions but the crystals were not of sufficient quality for diffraction studies. SDS gel analysis indicated that the protein had undergone proteolytic degradation. An increase in the use of protease inhibitors during purification eliminated proteolysis, but the intact protein did not crystallize. N-terminal sequencing and mass spectral analysis of dissolved crystals indicated that the protein had degraded to two major species consisting of residues 1-226 and 1-237. Expression of the 1-226 and 1-233 versions of human HO-1 provided active enzyme that crystallizes in a form suitable for diffraction studies. These crystals belong to space group P2(1), with unit cell dimensions a = 79.3 A, b = 56.3 A, c = 112.8 A, and beta = 101.5 degrees.  (+info)

Carbon monoxide stimulates the apical 70-pS K+ channel of the rat thick ascending limb. (2/201)

We have investigated the expression of heme oxygenase (HO) in the rat kidney and the effects of HO-dependent heme metabolites on the apical 70-pS K+ channel in the thick ascending limb (TAL). Reverse transcriptase-PCR (RT-PCR) and Western blot analyses indicate expression of the constitutive HO form, HO-2, in the rat cortex and outer medulla. Patch-clamping showed that application of 10 microM chromium mesoporphyrin (CrMP), an inhibitor of HO, reversibly reduced the activity of the apical 70-pS K+ channel, defined by NPo, to 26% of the control value. In contrast, addition of 10 microM magnesium protoporphyrin had no significant effect on channel activity. HO involvement in regulation of the apical 70-pS K+ channel of the TAL, was further indicated by the addition of 10 microM heme-L-lysinate, which significantly stimulated the channel activity in cell-attached patches by 98%. The stimulatory effect of heme on channel activity was also observed in inside-out patches in the presence of 0.5-1 mM reduced nicotinamide adenine dinucleotide phosphate. This was completely abolished by 10 microM CrMP, suggesting that a HO-dependent metabolite of heme mediated the effect. This was further supported by exposure of the cytosolic membrane of inside-out patches to a carbon monoxide-bubbled bath solution, which increased channel activity. Moreover, carbon monoxide completely abolished the effect of 10 microM CrMP on the channel activity. In contrast, 10 microM biliverdin, another HO-dependent metabolite of heme, had no effect. We conclude that carbon monoxide produced from heme via an HO-dependent metabolic pathway stimulates the apical 70-pS K+ channel in the rat TAL.  (+info)

The Arabidopsis thaliana HY1 locus, required for phytochrome-chromophore biosynthesis, encodes a protein related to heme oxygenases. (3/201)

The hy1 mutants of Arabidopsis thaliana fail to make the phytochrome-chromophore phytochromobilin and therefore are deficient in a wide range of phytochrome-mediated responses. Because this defect can be rescued by feeding seedlings biliverdin IXalpha, it is likely that the mutations affect an enzyme that converts heme to this phytochromobilin intermediate. By a combination of positional cloning and candidate-gene isolation, we have identified the HY1 gene and found it to be related to cyanobacterial, algal, and animal heme oxygenases. Three independent alleles of hy1 contain DNA lesions within the HY1 coding region, and a genomic sequence spanning the HY1 locus complements the hy1-1 mutation. HY1 is a member of a gene family and is expressed in a variety of A. thaliana tissues. Based on its homology, we propose that HY1 encodes a higher-plant heme oxygenase, designated AtHO1, responsible for catalyzing the reaction that opens the tetrapyrrole ring of heme to generate biliverdin IXalpha.  (+info)

Bacteriophytochromes: phytochrome-like photoreceptors from nonphotosynthetic eubacteria. (4/201)

Phytochromes are a family of photoreceptors used by green plants to entrain their development to the light environment. The distribution of these chromoproteins has been expanded beyond photoautotrophs with the discovery of phytochrome-like proteins in the nonphotosynthetic eubacteria Deinococcus radiodurans and Pseudomonas aeruginosa. Like plant phytochromes, the D. radiodurans receptor covalently binds linear tetrapyrroles autocatalytically to generate a photochromic holoprotein. However, the attachment site is distinct, using a histidine to potentially form a Schiff base linkage. Sequence homology and mutational analysis suggest that D. radiodurans bacteriophytochrome functions as a light-regulated histidine kinase, which helps protect the bacterium from visible light.  (+info)

Initial-rate kinetics of the flavin reductase reaction catalysed by human biliverdin-IXbeta reductase (BVR-B). (5/201)

The initial-rate kinetics of the flavin reductase reaction catalysed by biliverdin-IXbeta reductase at pH 7.5 are consistent with a rapid-equilibrium ordered mechanism, with the pyridine nucleotide binding first. NADPH binding to the free enzyme was characterized using stopped-flow fluorescence quenching, and a K(d) of 15.8 microM was calculated. Equilibrium fluorescence quenching experiments indicated a K(d) of 0.55 microM, suggesting that an enzyme-NADPH encounter complex (K(d) 15.8 microM) isomerizes to a more stable 'nucleotide-induced' conformation. The enzyme was shown to catalyse the reduction of FMN, FAD and riboflavin, with K(m) values of 52 microM, 125 microM and 53 microM, respectively. Lumichrome was shown to be a competitive inhibitor against FMN, with a K(i) of 76 microM, indicating that interactions with the isoalloxazine ring are probably sufficient for binding. During initial experiments it was observed that both the flavin reductase and biliverdin reductase activities of the enzyme exhibit a sharp optimum at pH 5 in citrate buffer. An initial-rate study indicated that the enzyme obeys a steady-state ordered mechanism in this buffer. The initial-rate kinetics in sodium acetate at pH 5 are consistent with a rapid-equilibrium ordered mechanism, indicating that citrate may directly affect the enzyme's behaviour at pH 5. Mesobiliverdin XIIIalpha, a synthetic biliverdin which binds to flavin reductase but does not act as a substrate for the enzyme, exhibits competitive kinetics with FMN (K(i) 0.59 microM) and mixed-inhibition kinetics with NADPH. This is consistent with a single pyridine nucleotide site and competition by FMN and biliverdin for a second site. Interestingly, flavin reductase/biliverdin-IXbeta reductase has also been shown to exhibit ferric reductase activity, with an apparent K(m) of 2.5 microM for the ferric iron. The ferric reductase reaction requires NAD(P)H and FMN. This activity is intriguing, as haem cleavage in the foetus produces non-alpha isomers of biliverdin and ferric iron, both of which are substrates for flavin reductase/biliverdin-IXbeta reductase.  (+info)

Reaction intermediates and single turnover rate constants for the oxidation of heme by human heme oxygenase-1. (6/201)

Heme oxygenase converts heme to biliverdin, iron, and CO in a reaction with two established intermediates, alpha-meso-hydroxyheme and verdoheme. Transient kinetic studies show that the conversion of Fe(3+)-heme to Fe(3+)-verdoheme is biphasic. Electron transfer to the heme (0.11 s(-1) at 4 degrees C and 0.49 s(-1) at 25 degrees C) followed by rapid O(2) binding yields the ferrous dioxy complex. Transfer of an electron (0.056 s(-1) at 4 degrees C and 0.21 s(-1) at 25 degrees C) to this complex triggers the formation of alpha-meso-hydroxyheme and its subsequent O(2)-dependent fragmentation to Fe(3+)-verdoheme. The conversion of Fe(3+)-verdoheme to Fe(3+)-biliverdin is also biphasic. Thus, reduction of Fe(3+) to Fe(2+)-verdoheme (0.15 s(-1) at 4 degrees C and 0.55 s(-1) at 25 degrees C) followed by O(2) binding and an electron transfer produces Fe(3+)-biliverdin (0.025 s(-1) at 4 degrees C and 0.10 s(-1) at 25 degrees C). The conversion of Fe(3+)-biliverdin to free biliverdin is triphasic. Reduction of Fe(3+)-biliverdin (0.035 s(-1) at 4 degrees C and 0.15 s(-1) at 25 degrees C), followed by rapid release of Fe(2+) (0.19 s(-1) at 4 degrees C and 0.39 s(-1) at 25 degrees C), yields the biliverdin-enzyme complex from which biliverdin slowly dissociates (0.007 s(-1) at 4 degrees C and 0.03 s(-1) at 25 degrees C). The rate of Fe(2+) release agrees with the rate of Fe(3+)-biliverdin reduction. Fe(2+) release clearly precedes biliverdin dissociation. In the absence of biliverdin reductase, biliverdin release is the rate-limiting step, but in its presence biliverdin release is accelerated and the overall rate of heme degradation is limited by the conversion of Fe(2+)-verdoheme to the Fe(3+)-biliverdin.  (+info)

Influence of bilirubin and other antioxidants on nitrergic relaxation in the pig gastric fundus. (7/201)

1. The influence of several antioxidants (bilirubin, urate, ascorbate, alpha-tocopherol, glutathione (GSH), Cu/Zn superoxide dismutase (SOD) and the manganese SOD mimic EUK-8) on nitrergic relaxations induced by either exogenous nitric oxide (NO; 10(-5) M) or electrical field stimulation (4 Hz; 10 s and 3 min) was studied in the pig gastric fundus. 2. Ascorbate (5x10(-4) M), alpha-tocopherol (4x10(-4) M), SOD (300 - 1000 u ml(-1)) and EUK-8 (3x10(-4) M) did not influence the relaxations to exogenous NO. In the presence of GSH (5x10(-4) M), the short-lasting relaxation to NO became biphasic, potentiated and prolonged. Urate (4x10(-4) M) and bilirubin (2x10(-4) M) also potentiated the relaxant effect of NO. None of the antioxidants influenced the electrically evoked relaxations. 3. 6-Anilino-5,8-quinolinedione (LY83583; 10(-5) M) had no influence on nitrergic nerve stimulation but nearly abolished the relaxant response to exogenous NO. Urate and GSH completely prevented this inhibitory effect, while it was partially reversed by SOD and bilirubin. Ascorbate, alpha-tocopherol and EUK-8 were without effect. 4. Hydroquinone (10(-4) M) did not affect the electrically induced nitrergic relaxations, but markedly reduced NO-induced relaxations. The inhibition of exogenous NO by hydroquinone was completely prevented by urate and GSH. SOD and ascorbate afforded partial protection, while bilirubin, EUK-8 and alpha-tocopherol were ineffective. 5. Hydroxocobalamin (10(-4) M) inhibited relaxations to NO by 50%, but not the electrically induced responses. Full protection versus this inhibitory effect was obtained with urate, GSH and alpha-tocopherol. 6. These results strengthen the hypothesis that several endogenous antioxidant defense mechanisms, enzymatic as well as non-enzymatic, might play a role in the nitrergic neurotransmission process.  (+info)

Arabidopsis phytochromes C and E have different spectral characteristics from those of phytochromes A and B. (8/201)

The red/far-red light absorbing phytochromes play a major role as sensor proteins in photomorphogenesis of plants. In Arabidopsis the phytochromes belong to a small gene family of five members, phytochrome A (phyA) to E (phyE). Knowledge of the dynamic properties of the phytochrome molecules is the basis of phytochrome signal transduction research. Beside photoconversion and destruction, dark reversion is a molecular property of some phytochromes. A possible role of dark reversion is the termination of signal transduction. Since Arabidopsis is a model plant for biological and genetic research, we focussed on spectroscopic characterization of Arabidopsis phytochromes, expressed in yeast. For the first time, we were able to determine the relative absorption maxima and minima for a phytochrome C (phyC) as 661/725 nm and for a phyE as 670/724 nm. The spectral characteristics of phyC and E are strictly different from those of phyA and B. Furthermore, we show that both phyC and phyE apoprotein chromophore adducts undergo a strong dark reversion. Difference spectra, monitored with phycocyanobilin and phytochromobilin as the apoprotein's chromophore, and in vivo dark reversion of the Arabidopsis phytochrome apoprotein phycocyanobilin adducts are discussed with respect to their physiological function.  (+info)

Biliverdine is a bile pigment that is produced when the liver breaks down hemoglobin, the protein in red blood cells that carries oxygen. It is a greenish-yellow compound that is excreted in the bile and can be detected in the urine and stool of individuals with liver disease or other conditions that affect bilirubin metabolism. In the medical field, biliverdine is often used as a diagnostic tool to help identify liver disease or other conditions that affect bilirubin metabolism. It can also be used as a treatment for certain types of liver disease, such as hepatitis C, by helping to reduce the amount of bilirubin in the blood and prevent liver damage.

Also biliverdine was present, a bile component expected in the liver. The blood might also partly have originated from the ...
... biliverdine MeSH D03.383.129.578.840.249.727 - urobilin MeSH D03.383.129.578.840.249.852 - urobilinogen MeSH D03.383.129.578. ... biliverdine MeSH D03.549.909.249.727 - urobilin MeSH D03.549.909.249.852 - urobilinogen MeSH D03.549.909.374 - chlorophyll MeSH ...
... biliverdine MeSH D23.767.193.727 - urobilin MeSH D23.767.193.852 - urobilinogen MeSH D23.767.261.050 - beta carotene MeSH ...
... biliverdine MeSH D04.345.783.249.727 - urobilin MeSH D04.345.783.249.852 - urobilinogen MeSH D04.345.783.374 - chlorophyll MeSH ...
Biliverdine D3.549.909.249.184.200 D3.633.400.909.249.184.200 Binding Sites, Antibody G12.425.143.232 G12.122.232 Binding, ...
Biliverdine D3.549.909.249.184.200 D3.633.400.909.249.184.200 Binding Sites, Antibody G12.425.143.232 G12.122.232 Binding, ...
Biliverdine D3.549.909.249.184.200 D3.633.400.909.249.184.200 Binding Sites, Antibody G12.425.143.232 G12.122.232 Binding, ...
Biliverdine D3.549.909.249.184.200 D3.633.400.909.249.184.200 Binding Sites, Antibody G12.425.143.232 G12.122.232 Binding, ...
Biliverdine D3.549.909.249.184.200 D3.633.400.909.249.184.200 Binding Sites, Antibody G12.425.143.232 G12.122.232 Binding, ...
Previous work demonstrated that the N-terminal domain (NTD) of SARS-CoV-2 spike binds biliverdin-a product of heme catabolism- ...
Uteroverdine use Biliverdine Uterus Utility Failure use Interruption of Services Supply Utilization and Quality Control Peer ...
Uteroverdine use Biliverdine Uterus Utility Failure use Interruption of Services Supply Utilization and Quality Control Peer ...
DeCS 2008 - March 17, 2008 version. ...
Uteroverdine use Biliverdine Uterus Utility Failure use Interruption of Services Supply Utilization and Quality Control Peer ...
Biliverdine / chemistry Actions. * Search in PubMed * Search in MeSH * Add to Search ...
MeSH Terms: Animals; Bilirubin/metabolism; Biliverdine/metabolism; Cytochrome P-450 Enzyme System/metabolism*; Heme/metabolism ...
Biliverdine / metabolism Actions. * Search in PubMed * Search in MeSH * Add to Search ...
Biliverdine D3.549.909.249.184.200 D3.633.400.909.249.184.200 Binding Sites, Antibody G12.425.143.232 G12.122.232 Binding, ...
Biliverdine Preferred Term Term UI T004805. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1976). ... Biliverdine Preferred Concept UI. M0002500. Registry Number. O9MIA842K9. Related Numbers. 114-25-0. Scope Note. 1,3,6,7- ... Biliverdine. Tree Number(s). D03.383.129.578.840.249.184.200. D03.633.400.909.249.184.200. D04.345.783.249.184.200. D23.767. ...
Biliverdine Preferred Term Term UI T004805. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1976). ... Biliverdine Preferred Concept UI. M0002500. Registry Number. O9MIA842K9. Related Numbers. 114-25-0. Scope Note. 1,3,6,7- ... Biliverdine. Tree Number(s). D03.383.129.578.840.249.184.200. D03.633.400.909.249.184.200. D04.345.783.249.184.200. D23.767. ...
... f we fail to find cholepyrrhine, we test next for biliverdine. Some urine is treated with a solution of sub-acetate of lead; a ... b.) Biliverdine, (bile green.) Chloroform constitutes the best means of isolating the two in mixtures, cholephyrrhine being ... If the alcohol assumes a green color, biliverdine is indicated. For further confirmation, we mix another quantity of urine with ... cholepyrrhine or biliver- dine. A small quantity of urine is poured on a white plate, and a drop of red (fuming) nitric acid ...
TETRAPIRROLES lineales que confieren su color característico a la BILIS y que incluyen: la BILIRRUBINA; la BILIVERDINA; y la ...
Biliverdina/fisiologia , Ácido Desoxicólico/fisiologia , Estresse Oxidativo , Animais , Biliverdina/farmacologia , Colestase/ ... Biliverdina/administração & dosagem , Biliverdina/farmacologia , Protetores contra Radiação/administração & dosagem , ... Catarata , Heme Oxigenase-1 , Animais , Bilirrubina/metabolismo , Biliverdina/metabolismo , Biliverdina/farmacologia , Catarata ... Biliverdina/farmacologia , Biliverdina/uso terapêutico , Complexo CD3/metabolismo , Proliferação de Células/efeitos dos ...
N0000006801 Bile Acids and Salts N0000007708 Bile Pigments N0000178891 Bile Salts N0000006844 Bilirubin N0000171215 Biliverdine ...
Biliverdine D3.549.909.249.184.200 D3.633.400.909.249.184.200 Binding Sites, Antibody G12.425.143.232 G12.122.232 Binding, ...
Biliverdine D3.549.909.249.184.200 D3.633.400.909.249.184.200 Binding Sites, Antibody G12.425.143.232 G12.122.232 Binding, ...
Uteroverdine use Biliverdine Uterus Utility Failure use Interruption of Services Supply Utilization and Quality Control Peer ...
Uteroverdina use Biliverdina UTI use Unidades de Terapia Intensiva UTI Neonatal use Unidades de Terapia Intensiva Neonatal ...
Uteroverdina use Biliverdina UTI use Unidades de Terapia Intensiva UTI Neonatal use Unidades de Terapia Intensiva Neonatal ...
Uteroverdina use Biliverdina UTI use Unidades de Terapia Intensiva UTI Neonatal use Unidades de Terapia Intensiva Neonatal ...
Uteroverdina use Biliverdina UTI use Unidades de Terapia Intensiva UTI Neonatal use Unidades de Terapia Intensiva Neonatal ...
Uteroverdina use Biliverdina. Utilização de Energia use Consumo de Energia. Utilização de Recursos Locais ...
Uteroverdina use Biliverdina UTI use Unidades de Terapia Intensiva UTI Neonatal use Unidades de Terapia Intensiva Neonatal ...

No FAQ available that match "biliverdine"